To gain further insight into the mechanisms of the NCX1/SERCA imbalance in a TAC-induced failing heart, the effects of a calmodulin antagonist on alterations of SERCA2 and NCX1 were examined 8 weeks following TAC treatment. The gene discussed is SLC8A1; the disease is persistent truncus arteriosus.